AC105 in Acute Spinal Cord Injury – Dr. Tony Caggiano

Acorda Therapeutics is performing a Phase 2 study of AC 105 in persons with acute spinal cord injury. Dr. Caggiano discusses the therapy and results from the Phase 1 study.

Without your valuable support of Unite 2 Fight Paralysis volunteers and your generous donations directed to the Working 2 Walk Video Library, the annual symposium video presentations could not be made possible for the paralysis community. (Thank you for your generous support in supplying this educational material for research and advocacy to cure paralysis).

This entry was posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Unite 2 Fight Paralysis, Working 2 Walk Science & Advocacy Symposium and tagged , , . Bookmark the permalink.